세계의 체외진단(IVD) 시약 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for IVD Reagents. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global IVD Reagents market from 2025 to 2032.

Key Insights:

• IVD Reagents Market Size (2025E): US$ 77.4 Bn
• Market Value Forecast (2032F): US$ 119.5 Bn
• Projected Growth (CAGR 2025 to 2032): 6.4%

IVD Reagents Market - Report Scope:

IVD (In Vitro Diagnostics) reagents are essential components used in diagnostic testing, facilitating the detection, monitoring, and treatment of various diseases. These reagents are widely used in clinical laboratories, hospitals, and research institutions for applications ranging from infectious disease testing to oncology and genetic testing. The growing emphasis on personalized medicine, increased prevalence of chronic diseases, and rising demand for point-of-care testing are key factors driving the market. Technological advancements in diagnostic techniques, such as molecular diagnostics and immunoassays, are further fueling the demand for IVD reagents.

Market Growth Drivers:

The global IVD reagents market is driven by several factors, including the rising burden of infectious diseases, chronic conditions such as cancer and diabetes, and the need for early disease detection. The adoption of advanced diagnostic technologies, such as next-generation sequencing (NGS) and polymerase chain reaction (PCR), is accelerating the demand for high-quality reagents. Additionally, the expansion of healthcare infrastructure, particularly in emerging economies, is facilitating greater access to diagnostic services. Government initiatives promoting early disease diagnosis and increased healthcare expenditure are also contributing to market growth.

Market Restraints:

Despite promising growth prospects, the IVD reagents market faces challenges such as stringent regulatory requirements and high costs associated with advanced diagnostic testing. The complexity of regulatory approvals for new reagents can delay market entry, impacting the development of innovative solutions. Additionally, concerns regarding the reproducibility and accuracy of test results may hinder market adoption. The high costs of specialized reagents, particularly in resource-limited settings, pose a barrier to widespread use, limiting market expansion in some regions.

Market Opportunities:

The IVD reagents market presents significant growth opportunities driven by ongoing advancements in diagnostic technologies and increasing investment in healthcare research. The rise of digital and AI-driven diagnostics is expected to enhance the efficiency and accuracy of testing, creating new avenues for market players. The growing trend of at-home and self-testing kits is also opening new revenue streams. Additionally, partnerships between reagent manufacturers and healthcare providers for the development of cost-effective solutions tailored to emerging markets offer lucrative opportunities. The increasing application of companion diagnostics in precision medicine is another key area of growth.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the IVD reagents market globally?
• How do advancements in molecular diagnostics impact the demand for IVD reagents?
• Which diagnostic segments are experiencing the highest growth within the market?
• Who are the key players in the IVD reagents market, and what strategies are they employing to maintain competitiveness?
• What are the emerging trends and future growth prospects in the global IVD reagents market?

Competitive Intelligence and Business Strategy:

Leading players in the global IVD reagents market, including Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Danaher Corporation, and Bio-Rad Laboratories, are focusing on research and development, strategic partnerships, and product innovation to strengthen their market position. Companies are investing in automation and digital healthcare solutions to enhance diagnostic capabilities. Collaborations with biotech firms and research institutions for the development of novel reagents are also a key strategy. The expansion of product portfolios through mergers and acquisitions is further shaping the competitive landscape of the market.

Key Companies Profiled:

• Abbott
• Agilent Technologies
• Becton Dickinson
• bioMerieux
• Bio-Rad
• Danaher
• DiaSorin
• Roche
• Seegene
• Sysmex
• Thermo Fisher Scientific
• Siemens Healthineers
• Transasia Bio-Medicals Ltd.
• Beacon Diagnostics Pvt. Ltd.

IVD Reagents Market Segmentation

By Type of Reagent

• Antibodies
• Antigens
• Oligonucleotides
• Enzymes
• Nucleic Acid Probes

By Technology

• Immunoassay
• Molecular Diagnostics
• Clinical Chemistry
• Hematology
• Microbiology

By Application

• Infectious Diseases
• Cancer/Oncology
• Cardiology
• Autoimmune Diseases
• Genetic Testing
• Neurology

By End-Use Industry

• Hospitals
• Clinical Laboratories
• Point-of-Care Testing Facilities
• Home Care Settings

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• The Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global IVD Reagents Market Snapshot, 2025-2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Regulatory Landscape
• 3.2. Application Epidemiology
• 3.3. Pipeline Analysis
• 3.4. Product Adoption Analysis
• 3.5. Value Chain Analysis
• 3.6. Key Promotional Strategies by Manufacturers
• 3.7. PESTLE Analysis
• 3.8. Porter's Five Force Analysis

4. Global IVD Reagents Market Outlook:

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Bn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
  • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
• 4.3. Global IVD Reagents Market Outlook: Type of Reagent
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Type of Reagent, 2019-2024
  • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 4.3.3.1. Antibodies
    • 4.3.3.2. Antigens
    • 4.3.3.3. Oligonucleotides
    • 4.3.3.4. Enzymes
    • 4.3.3.5. Nucleic Acid Probes
    • 4.3.3.6. Others
  • 4.3.4. Market Attractiveness Analysis: Type of Reagent
• 4.4. Global IVD Reagents Market Outlook: Technology
  • 4.4.1. Introduction / Key Findings
  • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Technology, 2019-2024
  • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 4.4.3.1. Immunoassay
    • 4.4.3.2. Molecular Diagnostics
    • 4.4.3.3. Clinical Chemistry
    • 4.4.3.4. Hematology
    • 4.4.3.5. Microbiology
    • 4.4.3.6. Others
  • 4.4.4. Market Attractiveness Analysis: Technology
• 4.5. Global IVD Reagents Market Outlook: Application
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
  • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 4.5.3.1. Infectious Diseases
    • 4.5.3.2. Cancer/Oncology
    • 4.5.3.3. Cardiology
    • 4.5.3.4. Autoimmune Diseases
    • 4.5.3.5. Genetic Testing
    • 4.5.3.6. Neurology
    • 4.5.3.7. Others
  • 4.5.4. Market Attractiveness Analysis: Application
• 4.6. Global IVD Reagents Market Outlook: End-Use Industry
  • 4.6.1. Introduction / Key Findings
  • 4.6.2. Historical Market Size (US$ Bn) Analysis, By End-Use Industry, 2019-2024
  • 4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 4.6.3.1. Hospitals
    • 4.6.3.2. Point-Of-Care Testing Facilities
    • 4.6.3.3. Home Care Settings
    • 4.6.3.4. Others
  • 4.6.4. Market Attractiveness Analysis: End-Use Industry

5. Global IVD Reagents Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
• 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America IVD Reagents Market Outlook:

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 6.2.1. By Country
  • 6.2.2. By Type of Reagent
  • 6.2.3. By Technology
  • 6.2.4. By Application
  • 6.2.5. By Application
  • 6.2.6. By End-Use Industry
• 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
  • 6.4.1. Antibodies
  • 6.4.2. Antigens
  • 6.4.3. Oligonucleotides
  • 6.4.4. Enzymes
  • 6.4.5. Nucleic Acid Probes
  • 6.4.6. Others
• 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
  • 6.5.1. Immunoassay
  • 6.5.2. Molecular Diagnostics
  • 6.5.3. Clinical Chemistry
  • 6.5.4. Hematology
  • 6.5.5. Microbiology
  • 6.5.6. Others
• 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 6.6.1. Infectious Diseases
  • 6.6.2. Cancer/Oncology
  • 6.6.3. Cardiology
  • 6.6.4. Autoimmune Diseases
  • 6.6.5. Genetic Testing
  • 6.6.6. Neurology
  • 6.6.7. Others
• 6.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
  • 6.7.1. Hospitals
  • 6.7.2. Point-Of-Care Testing Facilities
  • 6.7.3. Home Care Settings
  • 6.7.4. Others
• 6.8. Market Attractiveness Analysis

7. Europe IVD Reagents Market Outlook:

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Type of Reagent
  • 7.2.3. By Technology
  • 7.2.4. By Application
  • 7.2.5. By Application
  • 7.2.6. By End-Use Industry
• 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkey
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
  • 7.4.1. Antibodies
  • 7.4.2. Antigens
  • 7.4.3. Oligonucleotides
  • 7.4.4. Enzymes
  • 7.4.5. Nucleic Acid Probes
  • 7.4.6. Others
• 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
  • 7.5.1. Immunoassay
  • 7.5.2. Molecular Diagnostics
  • 7.5.3. Clinical Chemistry
  • 7.5.4. Hematology
  • 7.5.5. Microbiology
  • 7.5.6. Others
• 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 7.6.1. Infectious Diseases
  • 7.6.2. Cancer/Oncology
  • 7.6.3. Cardiology
  • 7.6.4. Autoimmune Diseases
  • 7.6.5. Genetic Testing
  • 7.6.6. Neurology
  • 7.6.7. Others
• 7.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
  • 7.7.1. Hospitals
  • 7.7.2. Point-Of-Care Testing Facilities
  • 7.7.3. Home Care Settings
  • 7.7.4. Others
• 7.8. Market Attractiveness Analysis

8. East Asia IVD Reagents Market Outlook:

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Type of Reagent
  • 8.2.3. By Technology
  • 8.2.4. By Application
  • 8.2.5. By Application
  • 8.2.6. By End-Use Industry
• 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
  • 8.4.1. Antibodies
  • 8.4.2. Antigens
  • 8.4.3. Oligonucleotides
  • 8.4.4. Enzymes
  • 8.4.5. Nucleic Acid Probes
  • 8.4.6. Others
• 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
  • 8.5.1. Immunoassay
  • 8.5.2. Molecular Diagnostics
  • 8.5.3. Clinical Chemistry
  • 8.5.4. Hematology
  • 8.5.5. Microbiology
  • 8.5.6. Others
• 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 8.6.1. Infectious Diseases
  • 8.6.2. Cancer/Oncology
  • 8.6.3. Cardiology
  • 8.6.4. Autoimmune Diseases
  • 8.6.5. Genetic Testing
  • 8.6.6. Neurology
  • 8.6.7. Others
• 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
  • 8.7.1. Hospitals
  • 8.7.2. Point-Of-Care Testing Facilities
  • 8.7.3. Home Care Settings
  • 8.7.4. Others
• 8.8. Market Attractiveness Analysis

9. South Asia & Oceania IVD Reagents Market Outlook:

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Type of Reagent
  • 9.2.3. By Technology
  • 9.2.4. By Application
  • 9.2.5. By Application
  • 9.2.6. By End-Use Industry
• 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
  • 9.4.1. Antibodies
  • 9.4.2. Antigens
  • 9.4.3. Oligonucleotides
  • 9.4.4. Enzymes
  • 9.4.5. Nucleic Acid Probes
  • 9.4.6. Others
• 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
  • 9.5.1. Immunoassay
  • 9.5.2. Molecular Diagnostics
  • 9.5.3. Clinical Chemistry
  • 9.5.4. Hematology
  • 9.5.5. Microbiology
  • 9.5.6. Others
• 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 9.6.1. Infectious Diseases
  • 9.6.2. Cancer/Oncology
  • 9.6.3. Cardiology
  • 9.6.4. Autoimmune Diseases
  • 9.6.5. Genetic Testing
  • 9.6.6. Neurology
  • 9.6.7. Others
• 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
  • 9.7.1. Hospitals
  • 9.7.2. Point-Of-Care Testing Facilities
  • 9.7.3. Home Care Settings
  • 9.7.4. Others
• 9.8. Market Attractiveness Analysis

10. Latin America IVD Reagents Market Outlook:

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Type of Reagent
  • 10.2.3. By Technology
  • 10.2.4. By Application
  • 10.2.5. By Application
  • 10.2.6. By End-Use Industry
• 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
  • 10.4.1. Antibodies
  • 10.4.2. Antigens
  • 10.4.3. Oligonucleotides
  • 10.4.4. Enzymes
  • 10.4.5. Nucleic Acid Probes
  • 10.4.6. Others
• 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
  • 10.5.1. Immunoassay
  • 10.5.2. Molecular Diagnostics
  • 10.5.3. Clinical Chemistry
  • 10.5.4. Hematology
  • 10.5.5. Microbiology
  • 10.5.6. Others
• 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 10.6.1. Infectious Diseases
  • 10.6.2. Cancer/Oncology
  • 10.6.3. Cardiology
  • 10.6.4. Autoimmune Diseases
  • 10.6.5. Genetic Testing
  • 10.6.6. Neurology
  • 10.6.7. Others
• 10.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
  • 10.7.1. Hospitals
  • 10.7.2. Point-Of-Care Testing Facilities
  • 10.7.3. Home Care Settings
  • 10.7.4. Others
• 10.8. Market Attractiveness Analysis

11. Middle East & Africa IVD Reagents Market Outlook:

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Type of Reagent
  • 11.2.3. By Technology
  • 11.2.4. By Application
  • 11.2.5. By Application
  • 11.2.6. By End-Use Industry
• 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
  • 11.4.1. Antibodies
  • 11.4.2. Antigens
  • 11.4.3. Oligonucleotides
  • 11.4.4. Enzymes
  • 11.4.5. Nucleic Acid Probes
  • 11.4.6. Others
• 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
  • 11.5.1. Immunoassay
  • 11.5.2. Molecular Diagnostics
  • 11.5.3. Clinical Chemistry
  • 11.5.4. Hematology
  • 11.5.5. Microbiology
  • 11.5.6. Others
• 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  • 11.6.1. Infectious Diseases
  • 11.6.2. Cancer/Oncology
  • 11.6.3. Cardiology
  • 11.6.4. Autoimmune Diseases
  • 11.6.5. Genetic Testing
  • 11.6.6. Neurology
  • 11.6.7. Others
• 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
  • 11.7.1. Hospitals
  • 11.7.2. Point-Of-Care Testing Facilities
  • 11.7.3. Home Care Settings
  • 11.7.4. Others
• 11.8. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2025
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Abbott
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. Michelin
  • 12.3.3. Agilent Technologies
  • 12.3.4. Becton Dickinson
  • 12.3.5. BioMerieux
  • 12.3.6. Bio-Rad
  • 12.3.7. Danaher
  • 12.3.8. DiaSorin
  • 12.3.9. Roche
  • 12.3.10. Seegene
  • 12.3.11. Sysmex
  • 12.3.12. Thermo Fisher Scientific
  • 12.3.13. Siemens Helthineers
  • 12.3.14. Transasia Bio-Medicals Ltd.
  • 12.3.15. Beacon Diagnostics Pvt. Ltd.
  • 12.3.16. Others

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations